Samsung Medical Center is a tertiary hospital located in Irwon-Dong of Gangnam-Gu, Seoul, South Korea. SMC is composed of Samsung Seoul Hospital, Kangbook Samsung Hospital, Samsung Changwon Hospital, and Samsung Life Sciences Research Center. SMC was founded on November 9, 1994.

During the past decade, Samsung Medical Center/Division of Nephrology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Samsung Medical Center/Division of Nephrology" are "Diabetic Nephropathies" (1 trials) and "Polycystic Kidney, Autosomal Dominant" (1 trials). Many other conditions were trialed in "Samsung Medical Center/Division of Nephrology" in a lesser frequency.

Most popular intervention types in "Samsung Medical Center/Division of Nephrology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Bosutinib" (1 trials) and "PF-00489791" (1 trials). Other intervention names were less common.

The vast majority of trials in "Samsung Medical Center/Division of Nephrology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Samsung Medical Center/Division of Nephrology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Samsung Medical Center/Division of Nephrology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Samsung Medical Center/Division of Nephrology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".